Literature DB >> 29511455

Interplay between long noncoding RNA ZEB1-AS1 and miR-101/ZEB1 axis regulates proliferation and migration of colorectal cancer cells.

Wan-Cheng Xiong1, Na Han2, Nan Wu3, Ke-Lei Zhao4, Chen Han3, Hui-Xin Wang3, Guan-Fang Ping3, Peng-Fei Zheng1, Hailong Feng1, Lei Qin5, Peng He1.   

Abstract

Long noncoding RNAs (lncRNAs) are dysregulated in many diseases. MicroRNA-101 (miR-101) functions as a tumor suppressor by directly targeting ZEB1 in various cancers. However, the potential mechanism of lncRNA ZEB1-AS1 and miR-101/ZEB1 axis in CRC remains unknown. In this study, we further investigated the potential interplay between miR-101/ZEB1 axis and lncRNA ZEB1-AS1 in colorectal cancer (CRC). Results showed that ZEB1-AS1 was upregulated in CRC tissues and cells. MiR-101 was downregulated in CRC tissues and negatively correlated with ZEB1-AS1 and ZEB1 expression levels in CRC. Functional experiments showed that, consistent with ZEB1-AS1 depletion, miR-101 overexpression and ZEB1 depletion inhibited the proliferation and migration of CRC cells. Overexpression of miR-101 partially abolished the effects of ZEB1-AS1 on the proliferation and migration of these cells. Moreover, combined ZEB1-AS1 depletion and miR-101 overexpression significantly inhibited cell proliferation and migration of the CRC cells. Hence, ZEB1-AS1 functioned as a molecular sponge for miR-101 and relieved the inhibition of ZEB1 caused by miR-101. This study revealed a novel regulatory mechanism between ZEB1-AS1 and miR-101/ZEB1 axis. The interplay between ZEB1-AS1 and miR-101/ZEB1 axis contributed to the proliferation and migration of CRC cells, and targeting this interplay could be a promising strategy for CRC treatment.

Entities:  

Keywords:  ZEB1; lncRNA ZEB1-AS1; miR-101; migration; proliferation

Year:  2018        PMID: 29511455      PMCID: PMC5835826     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  38 in total

1.  High expression of long non-coding RNA ZEB1-AS1 promotes colorectal cancer cell proliferation partially by suppressing p15 expression.

Authors:  Huangbo Gong; Hao Wen; Xuhui Zhu; Yifan Lian; Xiaojun Yang; Zhuyin Qian; Jin Zhu
Journal:  Tumour Biol       Date:  2017-06

Review 2.  A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer.

Authors:  Fausto Petrelli; Andrea Coinu; Veronica Lonati; Sandro Barni
Journal:  Int J Colorectal Dis       Date:  2014-11-30       Impact factor: 2.571

3.  Colorectal cancer statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Stacey A Fedewa; Dennis J Ahnen; Reinier G S Meester; Afsaneh Barzi; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-03-01       Impact factor: 508.702

4.  Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer.

Authors:  Peter Bronsert; Ilona Kohler; Sylvia Timme; Selina Kiefer; Martin Werner; Oliver Schilling; Yogesh Vashist; Frank Makowiec; Thomas Brabletz; Ulrich T Hopt; Dirk Bausch; Birte Kulemann; Tobias Keck; Ulrich F Wellner
Journal:  Surgery       Date:  2014-02-28       Impact factor: 3.982

Review 5.  Long noncoding RNAs: cellular address codes in development and disease.

Authors:  Pedro J Batista; Howard Y Chang
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

6.  Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1.

Authors:  Chibo Liu; Jianjun Lin
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

7.  MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells.

Authors:  Antonio Strillacci; Cristiana Griffoni; Pasquale Sansone; Paola Paterini; Giulia Piazzi; Giorgia Lazzarini; Enzo Spisni; Maria Abbondanza Pantaleo; Guido Biasco; Vittorio Tomasi
Journal:  Exp Cell Res       Date:  2008-12-24       Impact factor: 3.905

8.  MiRNA-101 inhibits oral squamous-cell carcinoma growth and metastasis by targeting zinc finger E-box binding homeobox 1.

Authors:  Baolei Wu; Delin Lei; Lei Wang; Xinjie Yang; Sen Jia; Zihui Yang; Chun Shan; Xi Yang; Chenping Zhang; Bin Lu
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

9.  Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma.

Authors:  T Li; J Xie; C Shen; D Cheng; Y Shi; Z Wu; X Deng; H Chen; B Shen; C Peng; H Li; Q Zhan; Z Zhu
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 8.756

10.  MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.

Authors:  Fei Guo; David Cogdell; Limei Hu; Da Yang; Anil K Sood; Fengxia Xue; Wei Zhang
Journal:  Oncol Rep       Date:  2014-03-21       Impact factor: 3.906

View more
  24 in total

1.  lncRNA RPSAP52 induced the development of tongue squamous cell carcinomas via miR-423-5p/MYBL2.

Authors:  Xiaozhen Wu; Zuode Gong; Long Ma; Qibao Wang
Journal:  J Cell Mol Med       Date:  2021-03-30       Impact factor: 5.310

2.  Construction of a novel mRNA-miRNA-lncRNA network and identification of potential regulatory axis associated with prognosis in colorectal cancer liver metastases.

Authors:  Chen Lu; Xiagang Luo; Cheng Xing; Yonghuan Mao; Yuting Xu; Wenjie Gao; Wulin Wang; Tian Zhan; Guoguang Wang; Zhengxia Liu; Chunzhao Yu
Journal:  Aging (Albany NY)       Date:  2021-06-03       Impact factor: 5.682

3.  Long noncoding RNA ZEB1-AS1 acts as a Sponge of miR-141-3p to Inhibit Cell Proliferation in Colorectal Cancer.

Authors:  Guanghai Wu; Mei Xue; Yongjie Zhao; Youkui Han; Chao Li; Shuai Zhang; Judong Zhang; Jing Xu
Journal:  Int J Med Sci       Date:  2020-06-27       Impact factor: 3.738

4.  The prognostic value of long noncoding RNA ZEB1-AS1 on clinical outcomes in human cancer.

Authors:  Ying Wu; Ming Ding; Shuzhen Wei; Ting Wu; Rongrong Xu; Xiaoli Zhu; Hongbing Liu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

5.  The Relationship Between ZEB1-AS1 Expression and the Prognosis of Patients With Advanced Gastric Cancer Receiving Chemotherapy.

Authors:  Haina Chai; Chao Sun; Jun Liu; Haihui Sheng; Renyan Zhao; Zhiqiang Feng
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

6.  ZEB1-AS1 initiates a miRNA-mediated ceRNA network to facilitate gastric cancer progression.

Authors:  Ming-Hui Ma; Jia-Xiang An; Cheng Zhang; Jie Liu; Yu Liang; Chun-Dong Zhang; Zhen Zhang; Dong-Qiu Dai
Journal:  Cancer Cell Int       Date:  2019-02-06       Impact factor: 5.722

7.  lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial-mesenchymal transition by competitively binding miR-141-3p.

Authors:  Weibin Qian; Xinrui Cai; Qiuhai Qian; Wei Peng; Jie Yu; Xinying Zhang; Li Tian; Can Wang
Journal:  Cell Death Dis       Date:  2019-02-12       Impact factor: 8.469

8.  The fibrotic microenvironment promotes the metastatic seeding of tumor cells into the lungs via mediating the ZEB1-AS1/miR-200b-3p/ZEB1 signaling.

Authors:  Jingjing Liu; Liming Cao; Jie Meng; Yuanyuan Li; Pengbo Deng; Pinhua Pan; Chengping Hu; Huaping Yang
Journal:  Cell Cycle       Date:  2020-10-05       Impact factor: 5.173

Review 9.  Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark.

Authors:  Shanshan Zhao; Xue Zhang; Shuo Chen; Song Zhang
Journal:  J Exp Clin Cancer Res       Date:  2020-09-14

Review 10.  The Dual Role of MicroRNAs in Colorectal Cancer Progression.

Authors:  Lei Ding; Zhenwei Lan; Xianhui Xiong; Hongshun Ao; Yingting Feng; Huan Gu; Min Yu; Qinghua Cui
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.